Collection of Peripheral Blood From Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia for Measuring Baseline Ascorbic Acid Levels and Future Epigenetic Cancer Research
Status: Completed
Location: See all (2) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
This study is a non-interventional, specimen collection translational study to evaluate vitamin C levels in the peripheral blood of Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), or Chronic Myelomonocytic Leukemia (CMML) patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients actively receiving treatment for acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML).
• Patients diagnosed with AML, MDS, or CMML and are treatment naïve.
• Patients who are 18 years old or older.
Locations
United States
Michigan
Cancer and Hematology Centers of Western Michigan
Grand Rapids
Metro Health - University of Michigan Health
Wyoming
Time Frame
Start Date: 2017-11-01
Completion Date: 2018-10-31
Participants
Target number of participants: 50
Treatments
AML, MDS, and CMML patients
Patients with a diagnosis of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML).
Authors
Related Therapeutic Areas
Sponsors
Leads: Van Andel Research Institute